These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 31941052)

  • 1. Pharmacological Mechanisms Involved in Sensory Gating Disruption Induced by (±)-3,4-Methylene- Dioxymethamphetamine (MDMA): Relevance to Schizophrenia.
    Lee J; Thwaites S; Gogos A; van den Buuse M
    Brain Sci; 2020 Jan; 10(1):. PubMed ID: 31941052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Schizophrenia-like disruptions of sensory gating by serotonin receptor stimulation in rats: effect of MDMA, DOI and 8-OH-DPAT.
    Thwaites SJ; Gogos A; Van den Buuse M
    Pharmacol Biochem Behav; 2013 Nov; 112():71-7. PubMed ID: 24120765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 5-HT modulation of auditory and visual sensorimotor gating: II. Effects of the 5-HT2A antagonist MDL 100,907 on disruption of sound and light prepulse inhibition produced by 5-HT agonists in Wistar rats.
    Padich RA; McCloskey TC; Kehne JH
    Psychopharmacology (Berl); 1996 Mar; 124(1-2):107-16. PubMed ID: 8935805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential effects of estrogen and testosterone on auditory sensory gating in rats.
    Thwaites SJ; van den Buuse M; Gogos A
    Psychopharmacology (Berl); 2014 Jan; 231(1):243-56. PubMed ID: 23929132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estrogen treatment blocks 8-hydroxy-2-dipropylaminotetralin- and apomorphine-induced disruptions of prepulse inhibition: involvement of dopamine D1 or D2 or serotonin 5-HT1A, 5-HT2A, or 5-HT7 receptors.
    Gogos A; Kwek P; Chavez C; van den Buuse M
    J Pharmacol Exp Ther; 2010 Apr; 333(1):218-27. PubMed ID: 20042529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of restraint and haloperidol on sensory gating in the midbrain of awake rats.
    Anstrom KK; Cromwell HC; Woodward DJ
    Neuroscience; 2007 May; 146(2):515-24. PubMed ID: 17360124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hippocampal and cortical sensory gating in rats: effects of quinpirole microinjections in nucleus accumbens core and shell.
    de Bruin NM; Ellenbroek BA; van Luijtelaar EL; Cools AR; Stevens KE
    Neuroscience; 2001; 105(1):169-80. PubMed ID: 11483310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modafinil disrupts prepulse inhibition in mice: strain differences and involvement of dopaminergic and serotonergic activation.
    Kwek P; van den Buuse M
    Eur J Pharmacol; 2013 Jan; 699(1-3):132-40. PubMed ID: 23219987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risperidone attenuates and reverses hyperthermia induced by 3,4-methylenedioxymethamphetamine (MDMA) in rats.
    Shioda K; Nisijima K; Yoshino T; Kuboshima K; Iwamura T; Yui K; Kato S
    Neurotoxicology; 2008 Nov; 29(6):1030-6. PubMed ID: 18722468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological characterizations of memantine-induced disruption of prepulse inhibition of the acoustic startle response in mice: involvement of dopamine D2 and 5-HT2A receptors.
    Nakaya K; Nakagawasai O; Arai Y; Onogi H; Sato A; Niijima F; Tan-No K; Tadano T
    Behav Brain Res; 2011 Mar; 218(1):165-73. PubMed ID: 21130810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopaminergic modulation of the P50 auditory-evoked potential in a computer model of the CA3 region of the hippocampus: its relationship to sensory gating in schizophrenia.
    Moxon KA; Gerhardt GA; Adler LE
    Biol Cybern; 2003 Apr; 88(4):265-75. PubMed ID: 12690485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of 5-HT2A and 5-HT2C/B receptors in the acute effects of 3,4-methylenedioxymethamphetamine (MDMA) on striatal single-unit activity and locomotion in freely moving rats.
    Ball KT; Rebec GV
    Psychopharmacology (Berl); 2005 Oct; 181(4):676-87. PubMed ID: 16001122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dopaminergic and noradrenergic modulation of amphetamine-induced changes in auditory gating.
    Stevens KE; Fuller LL; Rose GM
    Brain Res; 1991 Jul; 555(1):91-8. PubMed ID: 1681997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serotonin antagonists fail to alter MDMA self-administration in rats.
    Schenk S; Foote J; Aronsen D; Bukholt N; Highgate Q; Van de Wetering R; Webster J
    Pharmacol Biochem Behav; 2016 Sep; 148():38-45. PubMed ID: 27264435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cholinergic gating of hippocampal auditory evoked potentials in freely moving rats.
    Klinkenberg I; Sambeth A; Blokland A
    Eur Neuropsychopharmacol; 2013 Aug; 23(8):988-97. PubMed ID: 22974558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Actions of novel antipsychotic agents on apomorphine-induced PPI disruption: influence of combined serotonin 5-HT1A receptor activation and dopamine D2 receptor blockade.
    Auclair AL; Kleven MS; Besnard J; Depoortère R; Newman-Tancredi A
    Neuropsychopharmacology; 2006 Sep; 31(9):1900-9. PubMed ID: 16421514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acutely applied MDMA enhances long-term potentiation in rat hippocampus involving D1/D5 and 5-HT2 receptors through a polysynaptic mechanism.
    Rozas C; Loyola S; Ugarte G; Zeise ML; Reyes-Parada M; Pancetti F; Rojas P; Morales B
    Eur Neuropsychopharmacol; 2012 Aug; 22(8):584-95. PubMed ID: 22209363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The follow-up study on P50 auditory sensory gating in naïve schizophrenia].
    Wang HX; Zhang MD; Wang ZC; Chen XS; Lou FY; Liang JH; Chen C
    Zhonghua Yi Xue Za Zhi; 2010 Mar; 90(9):601-5. PubMed ID: 20450782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of the selective 5-HT2A receptor antagonist MDL 100,907 on MDMA-induced locomotor stimulation in rats.
    Kehne JH; Ketteler HJ; McCloskey TC; Sullivan CK; Dudley MW; Schmidt CJ
    Neuropsychopharmacology; 1996 Aug; 15(2):116-24. PubMed ID: 8840347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different P50 sensory gating measures reflect different cognitive dysfunctions in schizophrenia.
    Toyomaki A; Hashimoto N; Kako Y; Tomimatsu Y; Koyama T; Kusumi I
    Schizophr Res Cogn; 2015 Sep; 2(3):166-169. PubMed ID: 29379766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.